Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Inventory (2016 - 2019)

Ironwood Pharmaceuticals' Inventory history spans 8 years, with the latest figure at $648000.0 for Q4 2019.

  • On a quarterly basis, Inventory changed N/A to $648000.0 in Q4 2019 year-over-year; TTM through Dec 2019 was $648000.0, a N/A change, with the full-year FY2019 number at $648000.0, changed N/A from a year prior.
  • Inventory hit $648000.0 in Q4 2019 for Ironwood Pharmaceuticals, down from $2.3 million in the prior quarter.
  • Over the last five years, Inventory for IRWD hit a ceiling of $5.0 million in Q1 2015 and a floor of $76000.0 in Q3 2018.
  • Historically, Inventory has averaged $1.4 million across 5 years, with a median of $1.1 million in 2016.
  • Biggest five-year swings in Inventory: crashed 84.13% in 2018 and later surged 2923.68% in 2019.
  • Tracing IRWD's Inventory over 5 years: stood at $5.0 million in 2015, then tumbled by 78.16% to $1.1 million in 2016, then tumbled by 32.01% to $735000.0 in 2017, then tumbled by 89.66% to $76000.0 in 2018, then skyrocketed by 752.63% to $648000.0 in 2019.
  • Business Quant data shows Inventory for IRWD at $648000.0 in Q4 2019, $2.3 million in Q3 2019, and $1.7 million in Q2 2019.